Sponsors (26)
The bill increases VA availability and standardization of FDA‑cleared non‑opioid postoperative analgesics—potentially reducing opioid harms for veterans—at the cost of added VA expenditures, compressed implementation timelines, and timing uncertainty tied to CMS payment eligibility.
Veterans will receive faster, standardized access to FDA‑cleared non‑opioid postoperative analgesics because the VA must add eligible products to its national formulary within one year of CMS payment eligibility and place them on the VA drug standardization list.
Veterans and other patients undergoing surgery are likely to have reduced opioid exposure and related risks (dependence, overdose) due to expanded non‑opioid pain management options in VA care.
Taxpayers and VA beneficiaries may face higher VA operational costs because implementation and procurement must be funded from VA budgets (not the Cost of War Toxic Exposures Fund), potentially crowding out other VA spending or requiring additional appropriations.
VA medical centers and administrators will face administrative strain and compressed procurement timelines from the 90‑day/one‑year implementation requirements, risking uneven or limited initial availability at some facilities.
Veterans' access could be delayed because VA inclusion is tied to manufacturers securing CMS/Medicare payment eligibility, creating timing uncertainty between FDA clearance and actual availability in VA facilities.
Based on analysis of 2 sections of legislative text.
Requires the Department of Veterans Affairs to add FDA-approved/cleared non-opioid drugs and biological products for postoperative or regional analgesia to the VA national formulary and VA drug standardization list within set timeframes tied to CMS payment eligibility, and defines which products qualify. The law bars using the Cost of War Toxic Exposures Fund to implement these changes and directs the Secretary to put the amendments into effect within 90 days of enactment.
Introduced July 17, 2025 by Greg Landsman · Last progress July 17, 2025